Abstract
We treated a patient with type 2 diabetes suffering from chronic venous and neuro-ischemic wounds not healing under standard care with local application of autologous bone marrow cells (mBMC) isolated from bone marrow aspirate. This procedure led to a reduction of wound size, a markedly increased vascularization and infiltration of mononuclear cells, 7 days after treatment, without any signs of a systemic reaction to treatment. Locally applied mBMC could, therefore, provide a treatment option in end stage diabetic wound healing disorders.
Key words
Wound healing - type 2 diabetes - bone marrow cells
References
-
1
Boulton A J, Kirsner R S, Vileikyte L.
Clinical practice. Neuropathic diabetic foot ulcers.
N Engl J Med.
2004;
351
48-55
-
2
Kerosuo L, Juvonen E, Alitalo R, Gylling M, Kerjaschki D, Miettinen A.
Podocalyxin in human haematopoietic cells.
Br J Haematol.
2004;
124
809-818
-
3
Korbling M, Katz R L, Khanna A, Ruifrok A C, Rondon G, Albitar M, Champlin R E, Estrov Z.
Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells.
N Engl J Med.
2002;
346
738-746
-
4
Sivan-Loukianova E, Awad O A, Stepanovic V, Bickenbach J, Schatteman G C.
CD34+ blood cells accelerate vascularization and healing of diabetic mouse skin wounds.
J Vasc Res.
2003;
40
368-377
-
5
Stepanovic V, Awad O, Jiao C, Dunnwald M, Schatteman G C.
Leprdb diabetic mouse bone marrow cells inhibit skin wound vascularization but promote wound healing.
Circ Res.
2003;
92
1247-1253
-
6
Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, Amano K, Kishimoto Y, Yoshimoto K, Akashi H, Shimada K, Iwasaka T, Imaizumi T.
Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial.
Lancet.
2002;
360
427-435
Dr. Per M. Humpert
Medizinische Klinik 1
University of Heidelberg
INF 410
69120 Heidelberg
Telefon: + 496221568027
Fax: + 49 62 21 56 42 33
eMail: per.humpert@med.uni-heidelberg.de
